Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,152 INR | +1.81% | +5.96% | +6.25% |
Sales 2024 * | 287B 3.44B 4.7B | Sales 2025 * | 314B 3.77B 5.15B | Capitalization | 675B 8.09B 11.05B |
---|---|---|---|---|---|
Net income 2024 * | 31.44B 377M 515M | Net income 2025 * | 37.86B 454M 620M | EV / Sales 2024 * | 2.29 x |
Net cash position 2024 * | 18.34B 220M 300M | Net cash position 2025 * | 35.81B 429M 586M | EV / Sales 2025 * | 2.03 x |
P/E ratio 2024 * |
21.2
x | P/E ratio 2025 * |
17.4
x | Employees | 23,451 |
Yield 2024 * |
0.36% | Yield 2025 * |
0.44% | Free-Float | 47.93% |
Latest transcript on Aurobindo Pharma
1 day | +1.81% | ||
1 week | +5.96% | ||
Current month | +5.79% | ||
1 month | +5.79% | ||
3 months | +0.08% | ||
6 months | +34.80% | ||
Current year | +6.25% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 66 | 86-12-25 | |
Director of Finance/CFO | - | 12-12-31 | |
B. Adi Reddy
CMP | Compliance Officer | - | 16-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 66 | 86-12-25 | |
Founder | 66 | 86-12-25 | |
Director/Board Member | 64 | 03-05-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.32% | 6 M€ | +6.07% | - | |
0.22% | 18 M€ | +4.71% | ||
0.12% | 11 M€ | +2.69% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 1,152 | +1.81% | 2 471 250 |
24-04-26 | 1,131 | +2.53% | 1,511,617 |
24-04-25 | 1,103 | +1.78% | 1,642,872 |
24-04-24 | 1,084 | -0.84% | 923,839 |
24-04-23 | 1,093 | +1.58% | 1,150,312 |
Delayed Quote NSE India S.E., April 29, 2024 at 07:40 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.25% | 7.95B | |
+25.61% | 661B | |
+26.74% | 566B | |
-6.64% | 352B | |
+19.42% | 332B | |
+3.49% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.75% | 145B |
- Stock Market
- Equities
- AUROPHARMA Stock